Apoptosis inhibitor of macrophage and diabetic kidney disease

被引:0
|
作者
Timothy M. E. Davis
Kirsten E. Peters
Richard Lipscombe
机构
[1] University of Western Australia,Faculty of Health and Medical Sciences, Medical School
[2] Proteomics International,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:521 / 521
相关论文
共 50 条
  • [41] A Hyaluronan Synthesis Inhibitor Delays the Progression of Diabetic Kidney Disease in A Mouse Experimental Model
    Selman, Guillermo
    Martinez, Laisel
    Lightle, Andrea
    Aguilar, Alejandra
    Woltmann, Daniel
    Xiao, Yuxuan
    Vazquez-Padron, Roberto, I
    Salman, Loay H.
    KIDNEY360, 2021, 2 (05): : 809 - 818
  • [42] Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney disease
    Klein, Julie
    Caubet, Cecile
    Camus, Mylene
    Makridakis, Manousos
    Denis, Colette
    Gilet, Marion
    Feuillet, Guylene
    Rascalou, Simon
    Neau, Eric
    Garrigues, Luc
    du Boullay, Olivier Thillaye
    Mischak, Harald
    Monsarrat, Bernard
    Burlet-Schiltz, Odile
    Vlahou, Antonia
    Saulnier-Blache, Jean Sebastien
    Bascands, Jean-Loup
    Schanstra, Joost P.
    SCIENTIFIC REPORTS, 2020, 10 (01)
  • [43] Connectivity mapping of glomerular proteins identifies dimethylaminoparthenolide as a new inhibitor of diabetic kidney disease
    Julie Klein
    Cécile Caubet
    Mylène Camus
    Manousos Makridakis
    Colette Denis
    Marion Gilet
    Guylène Feuillet
    Simon Rascalou
    Eric Neau
    Luc Garrigues
    Olivier Thillaye du Boullay
    Harald Mischak
    Bernard Monsarrat
    Odile Burlet-Schiltz
    Antonia Vlahou
    Jean Sébastien Saulnier-Blache
    Jean-Loup Bascands
    Joost P. Schanstra
    Scientific Reports, 10
  • [44] Secretory leukocyte protease inhibitor as a novel predictive biomarker in patients with diabetic kidney disease
    Sun, Weiwei
    Yang, Hanwen
    Zhang, Jiale
    Wei, Shuwu
    Wu, Qiaoru
    Yang, Jie
    Cao, Can
    Cui, Zhaoli
    Zheng, Huijuan
    Wang, Yaoxian
    FRONTIERS IN ENDOCRINOLOGY, 2024, 15
  • [45] Apoptosis in polycystic kidney disease
    Goilav, Beatrice
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2011, 1812 (10): : 1272 - 1280
  • [46] The association between serum levels of apoptosis inhibitor of macrophage and the clinical features of nonalcoholic fatty liver disease
    Oda, Kohei
    Uto, Hirofumi
    Mawatari, Seiichi
    Tabu, Kazuaki
    Ohno, Kaori
    Toyokura, Eriko
    Oshige, Akihiko
    Imanaka, Dai
    Kumagai, Kotaro
    Tamai, Tsutomu
    Moriuchi, Akihiro
    Oketani, Makoto
    Ido, Akio
    Sumida, Yoshio
    Tsubouchi, Hirohito
    HEPATOLOGY, 2013, 58 : 558A - 558A
  • [47] Diabetic Kidney Disease - How to Protect the Kidney?
    Brenner, Susanne
    Wanner, Christoph
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2019, 144 (11) : 710 - 714
  • [48] Biomarkers of diabetic kidney disease
    Colhoun, Helen M.
    Marcovecchio, M. Loredana
    DIABETOLOGIA, 2018, 61 (05) : 996 - 1011
  • [49] Genetics of Diabetic Kidney Disease
    Florez, Jose C.
    SEMINARS IN NEPHROLOGY, 2016, 36 (06) : 474 - 480
  • [50] Managing diabetic kidney disease
    Zac-Varghese, Sagen
    Winocour, Peter
    BRITISH MEDICAL BULLETIN, 2018, 125 (01) : 55 - 66